| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.0019 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.0027 | 1 |